Arcturus Therapeutics Holdings Inc. Stock Forecast
Red day on Thursday for Arcturus Therapeutics Holdings Inc.
(Updated on May 02, 2024)
The Arcturus Therapeutics Holdings Inc. stock price fell by -4.98% on the last day (Thursday, 2nd May 2024) from $27.91 to $26.52. During the last trading day the stock fluctuated 8.25% from a day low at $26.00 to a day high of $28.14. The price has been going up and down for this period, and there has been a 0.76% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -234 thousand shares and in total, 693 thousand shares were bought and sold for approximately $18.37 million.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $25.11 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -30.43% during the next 3 months and, with a 90% probability hold a price between $17.47 and $22.49 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ARCT Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, April 30, 2024, and so far it has risen 3.72%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Arcturus Therapeutics Holdings Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $26.62 and $30.63. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Arcturus Therapeutics Holdings Inc. stock
Arcturus Therapeutics Holdings Inc. finds support from accumulated volume at $26.32 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.15 between high and low, or 8.25%. For the last week, the stock has had daily average volatility of 6.28%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ARCT) For The Upcoming Trading Day Of Friday 3rd
For the upcoming trading day on Friday, 3rd we expect Arcturus Therapeutics Holdings Inc. to open at $26.89, and during the day (based on 14 day Average True Range), to move between $24.68 and $28.36, which gives a possible trading interval of +/-$1.84 (+/-6.95%) up or down from last closing price. If Arcturus Therapeutics Holdings Inc. takes out the full calculated possible swing range there will be an estimated 13.90% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $26.32 (0.75%) than the resistance at $27.91 (5.24%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Arcturus Therapeutics Holdings Inc. will release earnings AMC on Wednesday, May 08, 2024.The consensus among the analysts for the expected earnings (EPS) is -$1.17. We will update the financials statements for Arcturus Therapeutics Holdings Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.04% in the first trading day after earnings release.
Is Arcturus Therapeutics Holdings Inc. stock A Buy?
Arcturus Therapeutics Holdings Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -3.770 Sell Candidate Unchanged
Predicted Opening Price for Arcturus Therapeutics Holdings Inc. of Friday, May 3, 2024
Fair opening price May 3, 2024 | Current price |
---|---|
$26.89 ( 1.38%) | $26.52 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ARCT
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 29.03 | 9.46 % | |
R2 | 28.21 | 6.37 % | ||
R1 | 27.70 | 4.47 % | ||
Current price: | 26.52 | |||
Support | S1 | 26.07 | -1.71 % | |
S2 | 25.56 | -3.62 % | ||
S3 | 24.74 | -6.71 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 33.13 | 24.92 % | |
R2 | 32.86 | 23.91 % | ||
R1 | 27.91 | 5.24 % | ||
Current price | 26.52 | |||
Support | S1 | 26.32 | -0.754% | |
S2 | 25.98 | -2.04% | ||
S3 | 25.57 | -3.58% |
ARCT Dividend Payout History
# | Ex-Date | Pay Date | Amount | Yield | |
---|---|---|---|---|---|
1 | Dec 27, 2012 | Jan 08, 2013 | Jan 15, 2013 | $0.0596 | 0% |
2 | Dec 28, 2012 | Jan 04, 2013 | Jan 15, 2013 | $0.0596 | 0% |
3 | Nov 28, 2012 | Dec 05, 2012 | Dec 15, 2012 | $0.0600 | 0% |
4 | Oct 26, 2012 | Nov 06, 2012 | Nov 15, 2012 | $0.0600 | 0% |
5 | Sep 27, 2012 | Oct 03, 2012 | Oct 15, 2012 | $0.0600 | 0% |
FAQ
Click here for our free guide on how to buy Arcturus Therapeutics Holdings Inc. Stock.